For arrhythmias and heart failure, guideline-directed therapies recommend heart failure drugs such as angiotensin-converting enzyme inhibitors (ACE-Is), angiotensin receptor blockers (ARBs), beta-blockers, sodium-glucose cotransporter 2 inhibitors, and mineralocorticoid receptor antagonists [116]. This evidence concerns the gene SLC5A2 and heart failure.